Dr. Schleicher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8 Brookhill Sq S
Ste 2A
Sugarloaf, PA 18249Phone+1 570-459-0029Fax+1 570-454-5757
Education & Training
- Temple University HospitalResidency, Dermatology, 1977 - 1980
- Rutgers Health/Monmouth Medical CenterInternship, Internal Medicine, 1976 - 1977
- Drexel University College of MedicineClass of 1976
Certifications & Licensure
- FL State Medical License 2002 - 2025
- MI State Medical License 2003 - 2025
- PA State Medical License 1977 - 2024
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EMA EMR, Modernizing Medicine, Inc., 2013
- Fellow (FAAD) American Academy of Dermatology
Publications & Presentations
PubMed
- Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson
Dermatology and Therapy. 2024-02-01 - 6 citationsTrifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study.Stephen Schleicher, Angela Moore, Elyse Rafal, Angelique Gagne-Henley, Sandra Marchese Johnson
Dermatology and Therapy. 2023-12-01 - Cutaneous Metastasis from Renal Cell Carcinoma.Megha D Patel, Stephen Schleicher
Skinmed. 2019-01-01
Press Mentions
- Top 5 Phase I Dermatology Clinical Trial SitesDecember 12th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: